Thomas Valerius
- Immunology top 0.5%
- Immune Cell Function and Interaction 29
- T-cell and B-cell Immunology 24
- Immunotherapy and Immune Responses 12
-
- Monoclonal and Polyclonal Antibodies Research 109
- Oncology top 1%
- CAR-T cell therapy research 26
- HER2/EGFR in Cancer Research 22
- Hematology top 1%
- Immunology and Allergy top 2%
-
- Glycosylation and Glycoproteins Research 49
-
- Chronic Lymphocytic Leukemia Research 17
- Co-authors
- Matthias PeippRoland ReppJan G. J. van de WinkelMichael DechantMartin GramatzkiPaul W.H.I. ParrenE PlatzerBernhard Stockmeyer
- Partner nations
- GermanyNetherlandsUnited States
In The Last Decade
Thomas Valerius
142 papers receiving 5.3k citations
Hit Papers
Peers
Comparison fields: 5 of 101
- Immunology 3.0k
- Radiology, Nuclear Medicine and Imaging 2.7k
- Oncology 1.9k
- Hematology 760
- Immunology and Allergy 291
Countries citing papers authored by Thomas Valerius
This map shows the geographic impact of Thomas Valerius's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Valerius with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Valerius more than expected).
Fields of papers citing papers by Thomas Valerius
This network shows the impact of papers produced by Thomas Valerius. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Valerius. The network helps show where Thomas Valerius may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Thomas Valerius, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2026 | 0 | |
| 2 | 2025 | 3 | |
| 3 | 2024 | 3 | |
| 4 | 2023 | 7 | |
| 5 | 2023 | 14 | |
| 6 | 2023 | 16 | |
| 7 | 2022 | 11 | |
| 8 | 2022 | 16 | |
| 9 | 2021 | 118 | |
| 10 | 2021 | 49 | |
| 11 | 2021 | 5 | |
| 12 | 2021 | 2 | |
| 13 | 2019 | 26 | |
| 14 | 2018 | 25 | |
| 15 | 2017 | 23 | |
| 16 | 2015 | 62 | |
| 17 | 2015 | 31 | |
| 18 | 2008 | 132 | |
| 19 | 2003 | 56 | |
| 20 | 2000 | 98 |
About Thomas Valerius
Thomas Valerius is a scholar working on Radiology, Nuclear Medicine and Imaging, Immunology and Oncology, having authored 145 papers that have together received 5.5k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (109 papers), Glycosylation and Glycoproteins Research (49 papers), Immune Cell Function and Interaction (29 papers), CAR-T cell therapy research (26 papers), T-cell and B-cell Immunology (24 papers), HER2/EGFR in Cancer Research (22 papers), Chronic Lymphocytic Leukemia Research (17 papers) and Immunotherapy and Immune Responses (12 papers). The work is most often cited by research in Immunology (3.0k citations), Radiology, Nuclear Medicine and Imaging (2.7k citations) and Oncology (1.9k citations). Thomas Valerius has collaborated with scholars based in Germany, Netherlands and United States. Frequent co-authors include Matthias Peipp, Roland Repp, Jan G. J. van de Winkel, Michael Dechant, Martin Gramatzki, Paul W.H.I. Parren, E Platzer, Bernhard Stockmeyer, Stefanie Derer and Wim K. Bleeker. Their work appears in journals such as Blood, The Journal of Immunology, Frontiers in Immunology, Journal of Immunological Methods and mAbs.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.